Digoxin In Treatment of Alcohol Associated Hepatitis
Condition(s):Acute Alcoholic Hepatitis; Chemical and Drug Induced Liver Injury; Alcohol-Induced Disorders; Steatohepatitis Caused by Ingestible AlcoholLast Updated:April 20, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Alcoholic Hepatitis; Chemical and Drug Induced Liver Injury; Alcohol-Induced Disorders; Steatohepatitis Caused by Ingestible AlcoholLast Updated:April 20, 2023Recruiting
Condition(s):Breast Cancer; Circulating Tumor Cells (CTCs)Last Updated:December 13, 2023Completed
Condition(s):Drug Drug InteractionLast Updated:May 1, 2023Completed
Condition(s):Heart FailureLast Updated:May 22, 2014Completed
Condition(s):Atrial FibrillationLast Updated:February 12, 2020Completed
Condition(s):Head and Neck CancerLast Updated:October 19, 2017Unknown status
Condition(s):Non-Medullary Thyroid CarcinomaLast Updated:August 4, 2023Active, not recruiting
Condition(s):HealthyLast Updated:October 12, 2022Completed
Condition(s):Pharmacokinetics of Isavuconazole; Pharmacokinetics of Digoxin; Healthy VolunteersLast Updated:September 1, 2015Completed
Condition(s):Abortion, InducedLast Updated:January 13, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.